3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Solid Tumors
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Vaginal Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Previously Treated Non Small Cell Lung Cancer
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Meningeal Carcinomatosis
1
Medulloblastoma
1
Lymphoid Interstitial Pneumonia
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Paclitaxel
6
Radiotherapy
2
Pemetrexed
2
Carboplatin
2
Brachytherapy
2
tucatinib
1
seribantumab
1
osimertinib
1
gedatolisib
1
fosaprepitant
1
fluciclovine F-18
1
cobimetinib
1
atezolizumab
1
alovudine
1
Trastuzumab
1
Therapeutics
1
TP protocol
1
Saline Solution
1
Radiation
1
Protons
1
Palliative Care
1
Nivolumab
1
Letrozole
1
Immunoglobulin G
1
Imatinib Mesylate
1
Ifosfamide
1
Gemcitabine
1
Fulvestrant
1
FANG vaccine
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Neoplasms
×
adavosertib
×
Clear all
No trials found.